SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-013540
Filing Date
2019-11-07
Accepted
2019-11-06 17:35:35
Documents
74
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aeri10-qx93019.htm   iXBRL 10-Q 1461360
2 EXHIBIT 31.1 aeri9302019ex311.htm EX-31.1 16403
3 EXHIBIT 31.2 aeri9302019ex312.htm EX-31.2 16500
4 EXHIBIT 32.1 aeri9302019ex321.htm EX-32.1 10032
5 EXHIBIT 32.2 aeri9302019ex322.htm EX-32.2 9974
  Complete submission text file 0001628280-19-013540.txt   6839877

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aeri-20190930.xsd EX-101.SCH 46500
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aeri-20190930_cal.xml EX-101.CAL 80271
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aeri-20190930_def.xml EX-101.DEF 225821
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aeri-20190930_lab.xml EX-101.LAB 685369
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aeri-20190930_pre.xml EX-101.PRE 387643
19 EXTRACTED XBRL INSTANCE DOCUMENT aeri10-qx93019_htm.xml XML 1089632
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36152 | Film No.: 191197464
SIC: 2836 Biological Products, (No Diagnostic Substances)